Qsam Biosciences Total Debt vs. EBITDA

QSAMDelisted Stock  USD 4.49  0.05  1.13%   
Based on Qsam Biosciences' profitability indicators, Qsam Biosciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Qsam Biosciences' ability to earn profits and add value for shareholders.
For Qsam Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Qsam Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Qsam Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Qsam Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Qsam Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between Qsam Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qsam Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qsam Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Qsam Biosciences EBITDA vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Qsam Biosciences's current stock value. Our valuation model uses many indicators to compare Qsam Biosciences value to that of its competitors to determine the firm's financial worth.
Qsam Biosciences is rated below average in total debt category among its peers. It is rated third in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Qsam Biosciences' earnings, one of the primary drivers of an investment's value.

Qsam Total Debt vs. Competition

Qsam Biosciences is rated below average in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 175.6 Million. Qsam Biosciences adds roughly 7,500 in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Capitalization  Revenue  Valuation  Workforce

Qsam EBITDA vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Qsam Biosciences

Total Debt

 = 

Bonds

+

Notes

 = 
7.5 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Qsam Biosciences

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(3.94 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Qsam EBITDA Comparison

Qsam Biosciences is currently under evaluation in ebitda category among its peers.

Qsam Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Qsam Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Qsam Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Qsam Biosciences' change in net profit over the period of time. It can combine multiple indicators of Qsam Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.

Qsam Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Qsam Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Qsam Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Qsam Biosciences' important profitability drivers and their relationship over time.

Use Qsam Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qsam Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qsam Biosciences will appreciate offsetting losses from the drop in the long position's value.

Qsam Biosciences Pair Trading

Qsam Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Qsam Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qsam Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qsam Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qsam Biosciences to buy it.
The correlation of Qsam Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qsam Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qsam Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qsam Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Qsam Biosciences position

In addition to having Qsam Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Outsourcing Thematic Idea Now

Outsourcing
Outsourcing Theme
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Qsam OTC Stock

If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets